Erector Spinae Plane Block Versus Quadratus Lumborum Block For Postoperative Analgesia After Abdominal Hysterectomy
1 other identifier
interventional
64
1 country
1
Brief Summary
The aim of this study is to compare the analgesic efficacy of erector spinae plane block and quadratus lumborum block after abdominal hysterectomy surgery and postoperative opioid consumption.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 7, 2022
CompletedFirst Submitted
Initial submission to the registry
September 13, 2022
CompletedFirst Posted
Study publicly available on registry
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 10, 2023
CompletedJuly 29, 2024
July 1, 2024
7 months
September 13, 2022
July 26, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Post-operative pain
Post-operative pain severity assessed by visual analog scale (VAS) (range from 0-10., 0 no pain, 10 worst pain ).
24 hours
Secondary Outcomes (2)
Cumulative post-operative opioid consumption
24 hours
The onset of 1st analgesic request
24 hours
Other Outcomes (1)
Incidence of complications
24 hours
Study Arms (2)
ESPB
ACTIVE COMPARATORErector Spinae Plane Block group
QLB
ACTIVE COMPARATORQuadratus Lumborum Block group
Interventions
Eligibility Criteria
You may qualify if:
- Patients with American Society of Anesthesiologists (ASA) physical status 1-3.
- scheduled for abdominal hysterectomy surgery.
You may not qualify if:
- History of allergy to the medications used in the study.
- Contraindication to regional anesthesia as coagulopathy, local infection.
- Severe hepatic impairment (child C).
- Sever Renal dysfunction (creatinine clearance \< 30).
- Psychiatric or mental disorder affecting patient ability to interpret VAS score.
- Body mass index (BMI) ≥ 40 or ≤ 18 kg/m2.
- ASA IV.
- Patient refusal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ain Shams univerisity
Cairo, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical assistant professor -Ain Shams University
Study Record Dates
First Submitted
September 13, 2022
First Posted
September 15, 2022
Study Start
July 7, 2022
Primary Completion
January 20, 2023
Study Completion
February 10, 2023
Last Updated
July 29, 2024
Record last verified: 2024-07